Financials data is unavailable for this security.
View more
Year on year Otsuka Holdings Co Ltd had net income fall -9.18% from 133.91bn to 121.62bn despite a 16.14% increase in revenues from 1.74tn to 2.02tn.
| Gross margin | 71.42% |
|---|---|
| Net profit margin | 6.84% |
| Operating margin | 8.72% |
| Return on assets | 4.42% |
|---|---|
| Return on equity | 6.07% |
| Return on investment | 5.59% |
More ▼
Cash flow in JPYView more
In 2023, Otsuka Holdings Co Ltd increased its cash reserves by 8.84%, or 41.71bn. The company earned 283.23bn from its operations for a Cash Flow Margin of 14.03%. In addition the company used 190.54bn on investing activities and also paid 60.26bn in financing cash flows.
| Cash flow per share | 484.94 |
|---|---|
| Price/Cash flow per share | 18.89 |
| Book value per share | 4,641.15 |
|---|---|
| Tangible book value per share | 2,974.00 |
More ▼
Balance sheet in JPYView more
| Current ratio | 1.92 |
|---|---|
| Quick ratio | 1.53 |
| Total debt/total equity | 0.1352 |
|---|---|
| Total debt/total capital | 0.1173 |
More ▼
Growth rates in JPY
Year on year, growth in dividends per share increased 10.00% while earnings per share excluding extraordinary items fell by -9.19%. The positive trend in dividend payments is noteworthy since very few companies in the Major Drugs industry pay a dividend. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 2.21% |
|---|---|
| Div growth rate (5 year) | 1.92% |
| Payout ratio (TTM) | 42.97% |
| EPS growth(5 years) | 8.18 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -17.82 |
More ▼
